132 filings
Page 4 of 7
8-K
jjvwle9k
2 Jun 21
Submission of Matters to a Vote of Security Holders
4:13pm
S-3ASR
7ognxmofott17qo05eux
18 May 21
Automatic shelf registration
6:01am
8-K
caa20cp1pmxn0s z8
13 May 21
Akero Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
7:18am
8-K
vxm5jdjg
26 Apr 21
Departure of Directors or Certain Officers
8:05am
8-K
7qnlooayrj86 1v6br
13 Apr 21
A Global Disease, A Pioneering Treatment Corporate Presentation April 2021
8:30am
8-K
ezap4a
23 Mar 21
Other Events
8:10am
8-K
flxn46s
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm
S-8
bkqutoid2corfkcvigd
18 Mar 21
Registration of securities for employees
4:53pm
8-K
spsxq7asd4xrjz
16 Mar 21
Akero Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
8:10am
8-K
m0qqa1oypttu5r0qp
12 Mar 21
Amendments to Articles of Incorporation or Bylaws
5:25pm
8-K
lc6ccu
11 Jan 21
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. JP Morgan Presentation January 2021
7:01am
8-K
k6ct80 82xw4eb3ydiv
16 Nov 20
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. Corporate Presentation November 2020
6:30am
8-K
th2fm
12 Nov 20
Akero Therapeutics Reports THIRD Quarter 2020 Financial Results
4:20pm
8-K
dj2mfhw
15 Oct 20
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. Corporate Presentation October 2020
8:30am
8-K
kf0fuhc
12 Aug 20
Akero Therapeutics Reports SECOND Quarter 2020 Financial Results
4:25pm